Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Company Overview - Apyx Medical Corporation is an advanced energy technology company focused on innovative products, including its Helium Plasma Platform Technology marketed as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market [3] - The effectiveness of Renuvion and J-Plasma is supported by over 90 clinical publications, demonstrating the company's commitment to clinical validation [3] Financial Results Announcement - Apyx Medical will release its financial results for the first quarter of fiscal year 2025 before markets open on Thursday, May 8th [1] - A conference call will be held at 8:00 a.m. Eastern Time on the same day to discuss the quarterly results and include a question-and-answer session [2] Investor Relations - The investor relations contact for Apyx Medical is Jeremy Feffer, Managing Director at LifeSci Advisors, who can be reached at 212-915-2568 or via email [3]